Clinical chemistry therapeutic drug monitoring IVDs
Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
Javno poročilo o oceni
(PAR)
09-11-2017
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Dostopno od:
Emergo Asia Pacific Pty Ltd T/a Emergo Australia
Razred:
Class 2
Izdeluje:
Utak Laboratories Inc 25020 Avenue Tibbitts, Valencia, CA, 91355 United States Of America
Terapevtsko območje:
CT860 - Clinical chemistry therapeutic drug monitoring IVDs
Terapevtske indikacije:
The UTAK controls are for use as quality control material for measuring the levels of anitepileptic drugs, antifungals, antipsychotics, immunosuppressive agents, pentobarbital, meprobamate, methotrexate, methylmalonic acid and other TDMs in serum, whole blood and urine. They are intended for use on a continuous basis so that a statistical evaluation of testing performance can be obtained.
Status dovoljenje:
A
Datum dovoljenje:
2014-02-05
